Involvement of PKC and NF-κB in nitric oxide induced apoptosis in human coronary artery smooth muscle cells

Cellular Physiology and Biochemistry

Volumn 11, Issue 5, 2001, Pages 231-240

  Ibe, Waltraut ^a   Bartels, Wolfgang ^a   Lindemann, Stephan ^a   Grosser, Tilo ^a   Buerke, Michael ^a   Boissel, Jean Paul ^a   Meyer, Juergen ^a   Darius, Harald ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Apoptosis; NF kB; NO donor; p53; PKC; Smooth muscle cells

Indexed keywords

C 93 4845; CALPHOSTIN C; CAS 1609; DACTINOMYCIN; DNA FRAGMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PROTEIN KINASE C; PROTEIN P53; STAUROSPORINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

EID: 0035742139     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047808     Document Type: Article

References (41)

1. Evidence for apoptosis in advanced human atheroma: Colocalization with interleukin-1β converting enzyme
2. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
3. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model
4. Apoptosis in human atherosclerosis and restenosis
5. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
6. S-nitroso-glutathione inhibits platelet activation in vitro and in vivo
7. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1-beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
8. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms
9. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signaling pathways
10. Chondrocyte apoptosis induced by nitric oxide
11. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53
12. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells
13. Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism
14. Vasoactive substances regulate vascular smooth muscle cell apoptosis
15. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells
16. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells
17. Inhibition of NF-κB DNA binding by nitric oxide
18. p53: DNA-damage, DNA repair and apoptosis
19. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells
20. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways
21. Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation
22. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding
23. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds
24. Programmed cell death induced by ceramide
25. Dependence of thymocyte apoptosis on protein kinase C and phospholipase 32
26. Potentiation of the activity of nitric oxide by the protein kinase C activator phorbol ester in human myeloid leukemic HL-60 cells: Association with enhanced fragmentation of mature genomic DNA
27. Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C.I. Fermentation, isolation, physico-chemical properties and biological activities
28. Nitric oxide donor-induced apoptosis in smooth muscle cells is modulated by protein kinase C and protein kinase A
29. Attenuation of p53 expression and Bax down-regulation during phorbol ester mediated inhibition of apoptosis
30. In vitro activation and nuclear translocation of NF-κB catalyzed by cyclic AMP-dependent protein kinase and protein kinase C
31. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB
32. Inhibition of NF-κB/Rel induces apoptosis of murine B cells
33. Inhibition of NF-κB activity induces apoptosis in murine hepatocytes
34. Nuclear Factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells
35. Vascular smooth muscle cells express a constitutive NF-κB-like activity
36. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-γ
37. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IκBα?
38. The nuclear factor κB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis
39. B-lymphocytes differentially use the rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
40. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro
41. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis